Medicine: Research
The question
To ask the Secretary of State for Science, Innovation and Technology, what proportion of UKRI and other research council funding was spent on (a) dementia, (b) cancer, (c) stroke and (d) coronary heart disease research in each year between 2019 and 2025.
Answered by Kanishka Narayan
The Medical Research Council (MRC), which is part of UK Research and Innovation (UKRI), supports world‑leading research to accelerate diagnosis, develop treatments and prevent disease.
Details of funding from MRC, as well as other research councils within UKRI, on specific areas is provided in the table below:
| 2019/20 | 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | Total |
(a)Dementia* |
|
|
|
|
|
|
|
MRC | £44m | £54m | £50m | £56m | £65m | £56m | £334m |
Rest of UKRI |
| £29m | £30m | £31m | £32m | £23m | £145m |
Total | £44m | £83m | £81m | £87m | £97m | £88m | £479m |
|
|
|
|
|
|
|
|
(b)Cancer |
|
|
|
|
|
|
|
MRC | £68m | £70m | £71m | £106m | £73m | £74m | £462m |
Rest of UKRI | £61m | £81m | £69m | £128m | £143m | £125m | £607m |
Total | £129m | £151m | £140m | £234m | £216m | £199m | £1069m |
|
|
|
|
|
|
|
|
(c)Stoke |
|
|
|
|
|
|
|
MRC | £47m | £9m | £21m | £10m | £15m | £20m | £121m |
Rest of UKRI | £6m | £30m | £12m | £31m | £50m | £30m | £148m |
Total | £53m | £39m | £33m | £41m | £65m | £50m | £269m |
|
|
|
|
|
|
|
|
(d) Coronary heart disease |
|
|
|
|
|
|
|
MRC | £73m | £18m | £29m | £44m | £32m | £64m | £260m |
Rest of UKRI | £23m | £24m | £25m | £49m | £84m | £55m | £260m |
Total | £96m | £42m | £54m | £93m | £116m | £119m | £520m |
|
|
|
|
|
|
|
|
*'Rest of UKRI' spend figure for 2019/20 is unavailable. For 2024/25, ‘Rest of UKRI’ figure does not include funding from the Natural Environment Research Council (NERC).
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →